Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125045612 | 12504561 | 2 | F | 20160610 | 20160711 | 20160628 | 20160720 | EXP | RO-KADMON PHARMACEUTICALS, LLC-KAD201606-002231 | KADMON | 58.53 | YR | F | Y | 0.00000 | 20160720 | CN | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125045612 | 12504561 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | FILM-COATED TABLET | 1055054 | 77456 | 600 | MG | FILM-COATED TABLET | BID | |||||
| 125045612 | 12504561 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | 1055054 | 77456 | |||||||||||
| 125045612 | 12504561 | 3 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | FILM-COATED TABLET | 1058724 | 0 | FILM-COATED TABLET | QD | |||||||
| 125045612 | 12504561 | 4 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 1058724 | 0 | |||||||||||
| 125045612 | 12504561 | 5 | SS | Exviera | DASABUVIR | 1 | Oral | FILM-COATED TABLET | 1059064 | 0 | FILM-COATED TABLET | BID | |||||||
| 125045612 | 12504561 | 6 | SS | Exviera | DASABUVIR | 1 | 1059064 | 0 | |||||||||||
| 125045612 | 12504561 | 7 | C | Enalapril | ENALAPRIL | 1 | Oral | TABLET | 0 | TABLET | |||||||||
| 125045612 | 12504561 | 8 | C | Tertensif | 2 | Oral | TABLET | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125045612 | 12504561 | 1 | Hepatitis C |
| 125045612 | 12504561 | 2 | Hepatic cirrhosis |
| 125045612 | 12504561 | 3 | Hepatitis C |
| 125045612 | 12504561 | 4 | Hepatic cirrhosis |
| 125045612 | 12504561 | 5 | Hepatitis C |
| 125045612 | 12504561 | 6 | Hepatic cirrhosis |
| 125045612 | 12504561 | 7 | Hypertension |
| 125045612 | 12504561 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125045612 | 12504561 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125045612 | 12504561 | Arteritis | |
| 125045612 | 12504561 | Asthenia | |
| 125045612 | 12504561 | Dizziness | |
| 125045612 | 12504561 | Headache | |
| 125045612 | 12504561 | Malaise | |
| 125045612 | 12504561 | Pruritus | |
| 125045612 | 12504561 | Skin exfoliation | |
| 125045612 | 12504561 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125045612 | 12504561 | 1 | 20160610 | 0 | ||
| 125045612 | 12504561 | 3 | 20160610 | 0 | ||
| 125045612 | 12504561 | 5 | 20160610 | 0 | ||
| 125045612 | 12504561 | 7 | 1996 | 0 | ||
| 125045612 | 12504561 | 8 | 1996 | 0 |